UPDATE: We have now completed enrolment for this study. Thank you for your interest. Stay tuned for news on the final number of women who enrolled and how many completed.
CeMCOR is now recruiting Canadian women for this CIHR-funded randomized controlled trial to test whether oral micronized progesterone is more effective than placebo as therapy for hot flushes and night sweats in perimenopausal women. The study is open to perimenopausal women 35 to 58 (who have menstruated within the past 12 months) with moderate-to-severe hot flushes (4 per day) and/or night sweats (waking twice weekly). Participants should not have used estrogen, progesterone, progestin or hormonal birth control within the past 6 months.
To obtain more details about your eligibility click here or call or e-mail study coordinator Andrea Cameron at the contact below.
Phone: (604)875-5960
Toll free: 1 855 875-5960
E-mail: andrea.cameron@ubc.ca
FREQUENTLY ASKED QUESTIONS
Click here for answers to frequently asked questions about perimenopause.
